Clinical and epidemiological characterization of tuberculosis at the Raoul Follereau Hospital. Guinea Bissau, 2024

Autores/as

Palabras clave:

Tuberculosis; Epidemiology; Risk Factors; Guinea Bissau; HIV

Resumen

Introduction: Tuberculosis (TB) remains one of the infectious diseases with the greatest global burden, especially in sub-Saharan Africa. In Guinea-Bissau, up-to-date clinical and epidemiological data are scarce, limiting local interventions.

Objective: To characterize diagnosed cases of tuberculosis according to sociodemographic, clinical, and epidemiological variables at Raoul Follereau Hospital during 2022.

Methods: Cross-sectional descriptive study. All 385 patients diagnosed with tuberculosis and admitted to the hospital were included. Data were obtained through review of medical records and statistical registers. Absolute and relative frequencies were analyzed.

Results: Males predominated (54.8%), as did the 60 years and older age group (25.5%). The most frequent occupation was "housewife" (48.6%). The main risk factors were alcoholism (63.6%) and malnutrition (52.2%). HIV was the most common comorbidity (22.6%). 80.8% of cases were bacteriologically confirmed.

Conclusions: There is a high frequency of modifiable risk factors (alcoholism, malnutrition) and comorbidities such as HIV in patients with tuberculosis. Local prevention and control strategies are needed to reduce transmission and move toward eliminating the disease.

Descargas

Los datos de descargas todavía no están disponibles.

Citas

1. World Health Organization. Tuberculosis. Geneva: WHO; [Internet] 2026 [citado 25/02/2026]. Disponible en: https://www.who.int/news-room/fact-sheets/detail/tuberculosis

2. World Health Organization. Global tuberculosis report 2024. Geneva: WHO; [Internet] 2024 [citado 25/02/2026]. Disponible en: https://www.who.int/teams/global-programme-on-tuberculosis-and-lung-health/tb-reports/global-tuberculosis-report-2024

3. Nanque AR, Ramos ACV, Moura HSD, Berra TZ, Tavares RBV, Monroe AA, Pinto IC, Arcêncio RA. Spatial and temporal analysis of tuberculosis incidence in Guinea-Bissau, 2018 to 2020. Rev Bras Enferm. 2023 Oct 9;76(4):e20220481. doi: 10.1590/0034-7167-2022-0481

4. Ministério da Saúde Pública da Guiné-Bissau (GW) Plano Estratégico Nacional de Luta Contra a Tuberculose 2020-2024. Bissau: Programa Nacional de Luta Contra Lepra e Tuberculose; 2020. p. 53.

5. Sousa GJB, Silva JCO, Queiroz TV, Bravo LG, Brito GCB, Pereira AS, et al. Clinical and epidemiological features of tuberculosis in children and adolescents. Rev Bras Enferm. 2019 Sep 16;72(5):1271-1278. doi: 10.1590/0034-7167-2018-0172

6. Franco JV, Bongaerts B, Metzendorf MI, Risso A, Guo Y, Peña Silva L, et al. Undernutrition as a risk factor for tuberculosis disease. Cochrane Database Syst Rev. 2024 Jun 11;6(6):CD015890. doi: 10.1002/14651858.CD015890.pub2.

7. Rehm J, Samokhvalov AV, Neuman MG, Room R, Parry C, Lönnroth K, et al. The association between alcohol use, alcohol use disorders and tuberculosis (TB): a systematic review. BMC Public Health. 2009 Dec 5;9:450. doi: 10.1186/1471-2458-9-450.

8. Hamada Y, Quartagno M, Law I, Malik F, Bonsu FA, Adetifa IMO, et al. Association of diabetes, smoking, and alcohol use with subclinical-to-symptomatic spectrum of tuberculosis in 16 countries: an individual participant data meta-analysis of national tuberculosis prevalence surveys. EClinicalMedicine. 2023 Aug 30;63:102191. doi: 10.1016/j.eclinm.2023.102191.

9. World Health Organization. Tuberculosis in the WHO African Region: 2023 progress update. Brazzaville: WHO Regional Office for Africa; [Internet] 2023 [citado 25/02/2026]. Disponible en: https://www.afro.who.int/publications/tuberculosis-who-african-region-2023-progress-update

10. Alene KA, Viney K, Moore HC, Wagaw M, Clements ACA. Spatial patterns of tuberculosis and HIV co-infection in Ethiopia. PLoS One. 2019;14(12):e0226127. doi: 10.1371/journal.pone.0226127.

11. Salla MR, Sá E, Ferreira PASC, Melo NA. Relação entre saneamento básico e saúde pública em Bissau, Guiné-Bissau. Saude Soc. 2019;28:284–296. doi: 10.1590/S0104-12902019180705.

12. Sánchez MA, Pino J, Pacheco R, García Goez JF. Análisis de letalidad en pacientes con diagnóstico de tuberculosis en un centro de alta complejidad en Cali, Colombia. Rev. Chilena. Infectol. [Internet]. 2018 [citado 25/02/2026]; 35(2). Disponible en: https://revinf.cl/index.php/revinf/article/view/52

13. Jam Rivero M, Valdivies YJ, Sierra DP, Jam Morales BC. Tuberculosis Pulmonar: estudio clínico-epidemiológico. Rev Cubana Med Gen Integr. [Internet] 2017 [citado 25/02/2026]; 33(3):321-330. Disponible en: http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S0864-21252017000300005

14. Williams PM, Pratt RH, Walker WL, Price SF, Stewart RJ, Feng PI. Tuberculosis - United States, 2023. MMWR Morb Mortal Wkly Rep. 2024 Mar 28;73(12):265-270. doi: 10.15585/mmwr.mm7312a4.

15. Ozer NT, Gundogan K. The Vicious Cycle of Malnutrition and Tuberculosis: A Narrative Review. J Clin Pract Res. 2024 Oct 25;46(5):444-448. doi: 10.14744/cpr.2024.60895.

16. Chung C, Lee KN, Han K, Shin DW, Lee SW. The effect of smoking on nontuberculous mycobacterial pulmonary disease and tuberculosis: a nationwide retrospective cohort study. Sci Rep. 2024 Sep 30;14(1):22653. doi: 10.1038/s41598-024-72438-4.

17. Wang EY, Arrazola RA, Mathema B, Ahluwalia IB, Mase SR. The impact of smoking on tuberculosis treatment outcomes: a meta-analysis. Int J Tuberc Lung Dis. 2020 Feb 1;24(2):170-175. doi: 10.5588/ijtld.19.0002.

18. Getahun DA, Layland LE, Hoerauf A, Wondale B. Impact of the use of GeneXpert on TB diagnosis and anti-TB treatment outcome at health facilities in Addis Ababa, Ethiopia in the post-millennium development years. PLoS One. 2023 Aug 25;18(8):e0289917. doi: 10.1371/journal.pone.0289917.

19. World Health Organization. Global tuberculosis report 2023. Geneva: WHO; [Internet] 2023 [citado 25/02/2026]. Disponible en: https://www.who.int/teams/global-programme-on-tuberculosis-and-lung-health/tb-reports/global-tuberculosis-report-2023

20. World Health Organization. WHO Rapid Communication: Key updates to the treatment of drug-resistant tuberculosis: rapid communication. Geneva: WHO; [Internet] 2024 [citado 25/02/2026]. Disponible en: https://www.who.int/publications/i/item/B09123

21. Perlaza CL, Mosquera FEC, Murillo LMR, Sepulveda VB, Arenas CDC. Factors of abandonment of tuberculosis treatment in the public health network. Rev Saude Publica. 2023 Apr 14;57:8. doi: 10.11606/s1518-8787.2023057004454.

Publicado

18-05-2026

Cómo citar

1.
Hernández-Barroso CM, Herrera-Santiesteban D de la C, Corbacho-Faulkner AC, Martínez-Quintana R, Arencibia-Almeida E, Carmona-Hernández C. Clinical and epidemiological characterization of tuberculosis at the Raoul Follereau Hospital. Guinea Bissau, 2024. MedEst [Internet]. 18 de mayo de 2026 [citado 22 de mayo de 2026];6:e480. Disponible en: https://revmedest.sld.cu/index.php/medest/article/view/480

Número

Sección

ARTÍCULO DE INVESTIGACIÓN